原发CD5阳性的弥漫大B细胞淋巴瘤

张倩; 张红宇

doi:10.13201/j.issn.1004-2806.2012.02.003

原发CD5阳性的弥漫大B细胞淋巴瘤

张倩,
张红宇^,

- 北京大学深圳医院血液内科(广东深圳, 518000)

详细信息

通讯作者: 张红宇,E-mail:ZYiqu@yahoo.com.cn

中图分类号: R733.4

收稿日期: 2011-09-14

修回日期: 2011-11-03

ZHANG Qian,
ZHANG Hongyu^,

Corresponding author: ZHANG Hongyu, E-mail: ZYiqu@yahoo.com.cn

Received Date: 14 September 2011

Revised Date: 03 November 2011

摘要

- 淋巴瘤,大B细胞性,弥漫性 /
- CD5 /
- 阳性 /
- 利妥昔单抗

HTML全文

参考文献(13)

[1]	MATOLCSY A,CHADBURN A,KNOWLES D M.De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct[J].Am J Pathol,1995,147:207-216.
[2]	KIPPS T J.The CD5 B cell[J].Adv Immunol,1989,47:117-185.
[3]	YAMAGUCHI M,SETO M,OKAMOTO M,et al.De novo CD5⁺ diffuse large B-cell lymphoma:clinicopathologic study of 109 patients[J].Blood,2002,99:815-821.
[4]	YAMAGUCHI M,NAKAMURA N,SUZUKI R,et al.De novo CD5⁺ diffuse large B-celllymphoma:results of a detailed clinicopathological review in 120 patients[J].Haematologica,2008,93:1195-1202.
[5]	NIITSU N,OKAMOTO M,TAMARU J,et al.Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma[J].Ann Oncol,2010,21:2069-2074.
[6]	TAGAWA H,TSUZUKI S,SUZUKI R,et al.Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma:comparison between CD5-positive and CD5-negative cases[J].Cancer Res,2004,64:5948-5955.
[7]	YOSHIOKA T,MIURA I,KUME M,et al.Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma:chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival[J].Genes Chromosomes Cancer,2005,42:149-157.
[8]	KARNAN S,TAGAWA H,SUZUKI R,et al.Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization[J].Genes Chromosomes Cancer,2004,39:77-81.
[9]	KATZENBERGER T,LOHR A,SCHWARZS,et al.Genetic analysis of de novo CD5⁺diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5⁺progenitor B cell[J].Blood,2003,101:699-702.
[10]	HANS C P,WEISENBURGER D D,GREINER T C,et al.Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray[J].Blood,2004,103:275-282.
[11]	MAESHIMA A M,TANIGUCHI H,NOMOTO J,et al.Secondary CD5⁺ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma(Richter syndrome)[J].Am J Clin Pathol,2009,131:339-346.
[12]	MIYAZAKI K,YAMAGUCHI M,SUZUKI R,et al.CD5-positive diffuse large B-cell lymphoma:a retrospective study in 337 patients treated by chemotherapy with or without rituximab[J].An Oncol,2011,22:1601-1607.
[13]	HYO R,TOMITA N,TAKEUCHI K,et al.The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma[J].Hematol Oncol,2010,28:27-32.